Risk factor for Alzheimer’s disease breaks the blood–brain barrier
Authors:
- Makoto IshiiMIMakoto Ishii
- Costantino IadecolaCICostantino Iadecola
- 29 April 2020
- journal article
- editorial
- Published by Springer Nature in Nature
- Vol. 581 (7806) , 31-32
Abstract
People who carry the gene variant APOE4 are at higher-than-average risk of developing Alzheimer’s disease. It emerges that this variant is linked to defects in the blood–brain barrier and subsequent cognitive decline. A link between APOE4 and breakdown of the blood–brain barrier.Keywords
This publication has 9 references indexed in Scilit:
- APOE4 leads to blood–brain barrier dysfunction predicting cognitive declineNature, 2020
- The blood–brain barrier in health and disease: Important unanswered questionsJournal of Experimental Medicine, 2020
- Alzheimer’s Disease and Vascular AgingJACC, 2020
- Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategiesNature Reviews Neurology, 2019
- Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer’s Disease ModelNeuron, 2019
- Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunctionNature Medicine, 2019
- Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive functionNature Communications, 2018
- Apolipoprotein E controls cerebrovascular integrity via cyclophilin ANature, 2012
- Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s diseaseProceedings of the National Academy of Sciences, 2006